drugset / Trial / NCT00320697
Smoking Relapse Prevention in Schizophrenia
RandomizedParallel-groupDouble-blindTreatment
Summary
This study seeks to determine if continued treatment with bupropion and nicotine replacement therapy (NRT) can reduce the smoking relapse rate in patients with schizophrenia.
Timeline
- Start
- 2006-04
- Primary completion
- 2008-10
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 300 mg | — |
| Subject | Nicotine | Unknown | 20 mg | — |
| Subject | Nicotine | Unknown | 21 mg | — |